Innovation Pharmaceuticals Inc (IPIX)

[farrell90]

There has been a lot of hyperbole and just plain BS on the board today and I thought I might as well join the fun. Obviously, a huge run like that would require a confluence of good news.

Brilacidin would have to demonstrate an unparalleled efficacy as a Covid 19 treatment.IPIX would have to have multiple funding options including federal and private sources and a bidding war for partners and drug licenses.

There are big numbers being thrown around for Covid19 treatments which may prove to be substantially inferior to Brilacidin.Arca recently had some modest news and traded 89 million shares in one day.

Recently an analyst projected a Remdesivir treatment course to be $5000 per patient with Gilead earnings of 6.7 billion by 2001.

"Porges, on Wednesday, estimated the drug will be priced at $4000 per course in Europe and $2000 for the same regimen in other markets. Overall, the forecast global remdesivir sales is $1.9 billion by the end of this year, jumping to $6.7 billion in 2021 (bolstered by government stockpiling) and then in a range of $5.8 to $6.9 billion in later years."

https://endpts.com/sp/bite-platform-and-the-evolution-toward-off-the-shelf-immuno-oncology-approaches/

IMO Brilacidin could prove to be a superior drug to Remdesivir. If Brilacidin could secure those projected revenues with 300 milllion shares, a 30 market multiple produces a price of $700 a share.

Big numbers. Is it possible for IPIX?

Time will tell.All IMO

GLTA,Farrell

Farrell